簡介

本頁面提供了有關 Mark C Wiggins 已知的內部交易歷史的全面分析。內部人士包括公司的高管、董事或重要投資者。一般而言,基於內幕、非公開信息進行交易是非法的。這並不意味著他們在自己的公司進行任何交易都是非法的。但是,他們必須透過Form 4向美國證券交易委員會(SEC)報告所有交易。盡管存在這些限制,學術研究表明,內部人士 - 整體而言 - 在自己公司中的投資表現往往優於市場。

平均交易盈利能力

「平均交易盈利能力」衡量了內部人士在過去三年中所有非計劃性的公開市場購買交易的平均回報率。計算過程包括檢查每筆交易,排除了作為10b5-1交易計劃的一部分的交易。然後,對每筆交易在3、6和12個月的表現進行平均,以生成該筆交易最終的表現指標。最終,將所有交易的表現指標進行平均,計算出內部人士的總體平均表現指標。列表僅包含在過去兩年中進行過至少三筆交易的內部人士。

如果內部人士的交易盈利能力顯示為"N/A",則可能是因為該內部人士在過去三年內沒有進行任何公開市場購買交易,或者他們進行的交易距離現在太近,無法計算出可靠的表現指標。

更新頻率:每日

查看收益最高的的內幕交易者列表。

報告內部持倉的公司

SEC文件顯示Mark C Wiggins已報告在以下公司擁有持倉或進行了交易:

證券 職位 最新報告的持倉
US:ZGNX / Zogenix Inc Director 0
US:TCON / TRACON Pharmaceuticals, Inc. Chief Business Officer 80,000
US:BIIB / Biogen Inc. EVP Corp. and Bus. Dev. 6,366
如何解讀這些圖表

以下圖表顯示了在Mark C Wiggins進行的每筆公開市場非計劃交易後證券的股價表現。非計劃交易是指沒有作為10b5-1交易計劃的一部分而進行的交易。股價表現以累積百分比變化的方式繪製。例如,如果一筆內部人士交易是在2019年1月1日進行的,該圖表將顯示該證券的每日百分比變化直至當前日期。如果在此期間股價從10美元漲至15美元,則股價的累積百分比變化將為50%。從10美元漲至20美元的價格變化將為100%,而從10美元跌至5美元的價格變化將為-50%。

最終,我們將評估內部人士的交易與股價的超額回報(正向或負向)之間的相關性,以判斷內部人士是否在交易中利用內部信息獲利。如果內部人士有這樣的行為,我們預期看到(a)購買後的正回報,或者(b)賣出後的負回報。對於情況(a),購買圖表將顯示一系列向上傾斜的曲線,表示每次購買後都有正回報。對於情況(b),賣出圖表將顯示一系列向下傾斜的曲線,表示每次賣出後都有負回報。

然而,僅憑這一點還不足以得出結論。例如,如果公司的股價在多年內呈現非周期性上升,我們會預期所有購買後的圖表都呈現向上傾斜。同樣地,多年來呈現非周期性下降的股價會導致賣出後的圖表也呈現向下傾斜。這兩種情況的圖表都不能表示內部人士在進行內幕交易。

最有力的指標是在公司股價呈極度循環波動的情況下,「購買」圖表顯示正向信號,而「賣出」圖表顯示負向趨勢。這種情況強烈暗示內部人士可能根據內幕信息精確地計時進行交易,以獲得財務優勢。

歷史內部人交易

該表格顯示了由 Mark C Wiggins 進行的所有內幕交易的完整列表,這些交易已向美國證券交易委員會(SEC)披露。

呈報日期 交易日期 表格 證券代碼 證券 代碼 10b5-1 股份 剩餘股份 %
變化
每股
股價
交易
金額
剩餘
金額
2022-03-09 2022-03-07 4 ZGNX ZOGENIX, INC.
Stock Option (Right to Buy)
D - Sale to Issuer -22,000 0 -100.00
2022-03-09 2022-03-07 4 ZGNX ZOGENIX, INC.
Stock Option (Right to Buy)
D - Sale to Issuer -20,000 0 -100.00
2022-03-09 2022-03-07 4 ZGNX ZOGENIX, INC.
Stock Option (Right to Buy)
D - Sale to Issuer -20,000 0 -100.00
2022-03-09 2022-03-07 4 ZGNX ZOGENIX, INC.
Stock Option (Right to Buy)
D - Sale to Issuer -9,000 0 -100.00
2022-03-09 2022-03-07 4 ZGNX ZOGENIX, INC.
Stock Option (Right to Buy)
D - Sale to Issuer -6,250 0 -100.00
2022-03-09 2022-03-07 4 ZGNX ZOGENIX, INC.
Stock Option (Right to Buy)
D - Sale to Issuer -5,625 0 -100.00
2022-03-09 2022-03-07 4 ZGNX ZOGENIX, INC.
Stock Option (Right to Buy)
D - Sale to Issuer -4,375 0 -100.00
2022-03-09 2022-03-07 4 ZGNX ZOGENIX, INC.
Common Stock
U - Other -2,500 0 -100.00
2022-02-01 2022-01-28 4 TCON Tracon Pharmaceuticals, Inc.
Employee Stock Option (Right to Buy)
A - Award 80,000 80,000
2021-05-28 2021-05-27 4 ZGNX ZOGENIX, INC.
Stock Option (Right to Buy)
A - Award 22,000 22,000
2021-02-02 2021-01-29 4 TCON Tracon Pharmaceuticals, Inc.
Employee Stock Option (Right to Buy)
A - Award 55,000 55,000
2020-12-30 2020-12-29 4 TCON Tracon Pharmaceuticals, Inc.
Common Stock
P - Purchase 3 13,700 0.02 10.56 32 144,672
2020-12-30 2020-12-29 4 TCON Tracon Pharmaceuticals, Inc.
Common Stock
P - Purchase 997 13,697 7.85 10.57 10,538 144,777
2020-09-14 2020-09-10 4 TCON Tracon Pharmaceuticals, Inc.
Common Stock
P - Purchase 7,000 12,350 130.84 4.14 28,953 51,081
2020-03-24 2020-03-23 4 ZGNX ZOGENIX, INC.
Common Stock
P - Purchase 2,500 2,500 20.48 51,196 51,196
2020-02-04 2020-01-31 4 TCON Tracon Pharmaceuticals, Inc.
Employee Stock Option (Right to Buy)
A - Award 22,000 22,000
2020-01-24 2020-01-23 4 TCON Tracon Pharmaceuticals, Inc.
Common Stock
P - Purchase 5,000 5,000 4.02 20,102 20,102
2019-08-12 2019-08-09 4 ZGNX ZOGENIX, INC.
Stock Option (Right to Buy)
M - Exercise X -6,250 0 -100.00
2019-08-12 2019-08-09 4 ZGNX ZOGENIX, INC.
Common Stock
S - Sale X -6,250 0 -100.00 50.00 -312,500
2019-08-12 2019-08-09 4 ZGNX ZOGENIX, INC.
Common Stock
M - Exercise X 6,250 6,250 15.04 94,000 94,000
2019-05-28 2019-05-22 4 ZGNX ZOGENIX, INC.
Stock Option (Right to Buy)
A - Award 13,000 13,000
2018-05-30 2018-05-29 4 TCON Tracon Pharmaceuticals, Inc.
Employee Stock Option (Right to Buy)
A - Award 280,000 280,000
2018-05-24 2018-05-23 4 ZGNX ZOGENIX, INC.
Stock Option (Right to Buy)
A - Award 15,000 15,000
2017-05-23 2017-05-23 4 ZGNX ZOGENIX, INC.
Stock Option (Right to Buy)
A - Award 20,000 20,000
2016-07-15 2016-07-13 4 ZGNX ZOGENIX, INC.
Stock Option (Right to Buy)
A - Award 20,000 20,000
2015-06-19 2015-06-18 4 ZGNX ZOGENIX, INC.
Stock Option (Right to Buy)
A - Award 72,000 72,000
2014-05-22 2014-05-21 4 ZGNX ZOGENIX, INC.
Right to buy stock
A - Award 50,000 205,000 32.26
2013-06-19 2013-06-18 4 ZGNX ZOGENIX, INC.
Right to buy stock
A - Award 45,000 155,000 40.91
2012-06-06 2012-06-06 4 ZGNX ZOGENIX, INC.
Right to buy stock
A - Award 35,000 110,000 46.67
2012-04-30 2012-04-27 4 ZGNX ZOGENIX, INC.
Right to buy stock
A - Award 50,000 75,000 200.00
2008-02-07 2008-02-06 4 BIIB BIOGEN IDEC INC.
Restricted Stock Unit
M - Exercise -6,367 6,366 -50.00
2008-02-07 2008-02-06 4 BIIB BIOGEN IDEC INC.
Stock Option (right to buy)
M - Exercise X -11,925 23,850 -33.33
2008-02-07 2008-02-06 4 BIIB BIOGEN IDEC INC.
Common Stock
S - Sale X -3,000 16,521 -15.37 61.87 -185,610 1,022,135
2008-02-07 2008-02-06 4 BIIB BIOGEN IDEC INC.
Common Stock
S - Sale X -100 19,521 -0.51 61.70 -6,170 1,204,426
2008-02-07 2008-02-06 4 BIIB BIOGEN IDEC INC.
Common Stock
S - Sale X -100 19,621 -0.51 61.61 -6,161 1,208,830
2008-02-07 2008-02-06 4 BIIB BIOGEN IDEC INC.
Common Stock
S - Sale X -300 19,721 -1.50 61.60 -18,480 1,214,794
2008-02-07 2008-02-06 4 BIIB BIOGEN IDEC INC.
Common Stock
S - Sale X -200 20,021 -0.99 61.23 -12,246 1,225,866
2008-02-07 2008-02-06 4 BIIB BIOGEN IDEC INC.
Common Stock
S - Sale X -100 20,221 -0.49 61.22 -6,122 1,237,910
2008-02-07 2008-02-06 4 BIIB BIOGEN IDEC INC.
Common Stock
S - Sale X -600 20,321 -2.87 61.19 -36,714 1,243,423
2008-02-07 2008-02-06 4 BIIB BIOGEN IDEC INC.
Common Stock
S - Sale X -300 20,921 -1.41 61.18 -18,354 1,279,927
2008-02-07 2008-02-06 4 BIIB BIOGEN IDEC INC.
Common Stock
S - Sale X -500 21,221 -2.30 61.17 -30,585 1,298,069
2008-02-07 2008-02-06 4 BIIB BIOGEN IDEC INC.
Common Stock
S - Sale X -300 21,721 -1.36 61.16 -18,348 1,328,437
2008-02-07 2008-02-06 4 BIIB BIOGEN IDEC INC.
Common Stock
S - Sale X -600 22,021 -2.65 61.15 -36,690 1,346,565
2008-02-07 2008-02-06 4 BIIB BIOGEN IDEC INC.
Common Stock
S - Sale X -400 22,621 -1.74 61.14 -24,456 1,383,028
2008-02-07 2008-02-06 4 BIIB BIOGEN IDEC INC.
Common Stock
S - Sale X -600 23,021 -2.54 61.13 -36,678 1,407,254
2008-02-07 2008-02-06 4 BIIB BIOGEN IDEC INC.
Common Stock
S - Sale X -600 23,621 -2.48 61.12 -36,672 1,443,696
2008-02-07 2008-02-06 4 BIIB BIOGEN IDEC INC.
Common Stock
S - Sale X -1,600 24,221 -6.20 61.11 -97,776 1,480,126
2008-02-07 2008-02-06 4 BIIB BIOGEN IDEC INC.
Common Stock
S - Sale X -400 25,821 -1.53 61.10 -24,440 1,577,644
2008-02-07 2008-02-06 4 BIIB BIOGEN IDEC INC.
Common Stock
S - Sale X -700 26,221 -2.60 61.08 -42,756 1,601,559
2008-02-07 2008-02-06 4 BIIB BIOGEN IDEC INC.
Common Stock
S - Sale X -200 26,921 -0.74 60.99 -12,198 1,641,892
2008-02-07 2008-02-06 4 BIIB BIOGEN IDEC INC.
Common Stock
S - Sale X -200 27,121 -0.73 60.81 -12,162 1,649,209
2008-02-07 2008-02-06 4 BIIB BIOGEN IDEC INC.
Common Stock
S - Sale X -800 27,321 -2.84 60.80 -48,640 1,661,097
2008-02-07 2008-02-06 4 BIIB BIOGEN IDEC INC.
Common Stock
S - Sale X -225 28,121 -0.79 60.69 -13,655 1,706,644
2008-02-07 2008-02-06 4 BIIB BIOGEN IDEC INC.
Common Stock
S - Sale X -100 28,346 -0.35 60.64 -6,064 1,718,882
2008-02-07 2008-02-06 4 BIIB BIOGEN IDEC INC.
Common Stock
M - Exercise X 11,925 28,446 72.18 44.24 527,562 1,258,437
2008-02-07 2008-02-06 4 BIIB BIOGEN IDEC INC.
Common Stock
F - Taxes -2,081 16,521 -11.19 60.52 -125,942 999,832
2008-02-07 2008-02-06 4 BIIB BIOGEN IDEC INC.
Common Stock
M - Exercise 6,367 18,602 52.04
2007-02-08 2007-02-06 4 BIIB BIOGEN IDEC INC
Restricted Stock Unit
D - Sale to Issuer -6,367 12,733 -33.34
2007-02-08 2007-02-06 4 BIIB BIOGEN IDEC INC
Common Stock
F - Taxes -4,930 21,329 -18.77 48.94 -241,274 1,043,847
2007-02-08 2007-02-06 4 BIIB BIOGEN IDEC INC
Common Stock
M - Exercise 6,367 26,259 32.01
2006-02-08 2006-02-06 4 BIIB BIOGEN IDEC INC
Restricted Stock Units
A - Award 19,100 19,100
2006-02-08 2006-02-06 4 BIIB BIOGEN IDEC INC
Stock Option (right-to-buy)
A - Award 47,700 47,700
2005-02-22 2005-02-17 4 BIIB BIOGEN IDEC INC
Stock Option (right-to-buy)
A - Award 51,000 51,000
2004-08-03 2004-07-30 4 BIIB BIOGEN IDEC INC
Stock Option (right-to-buy)
M - Exercise -6,318 3,632 -63.50
2004-08-03 2004-07-30 4 BIIB BIOGEN IDEC INC
Stock Option (right-to-buy)
M - Exercise -10,000 91,500 -9.85
2004-08-03 2004-07-30 4 BIIB BIOGEN IDEC INC
Common Stock
S - Sale -6,318 3,632 -63.50 60.06 -379,459 218,138
2004-08-03 2004-07-30 4 BIIB BIOGEN IDEC INC
Common Stock
M - Exercise 6,318 9,950 173.95 5.58 35,273 55,551
2004-08-03 2004-07-30 4 BIIB BIOGEN IDEC INC
Common Stock
S - Sale -2,082 91,500 -2.22 60.06 -125,045 5,495,490
2004-08-03 2004-07-30 4 BIIB BIOGEN IDEC INC
Common Stock
S - Sale -2,769 93,582 -2.87 60.05 -166,278 5,619,599
2004-08-03 2004-07-30 4 BIIB BIOGEN IDEC INC
Common Stock
S - Sale -1,600 96,351 -1.63 59.98 -95,968 5,779,133
2004-08-03 2004-07-30 4 BIIB BIOGEN IDEC INC
Common Stock
S - Sale -1,249 97,951 -1.26 59.91 -74,828 5,868,244
2004-08-03 2004-07-30 4 BIIB BIOGEN IDEC INC
Common Stock
S - Sale -1,000 99,200 -1.00 59.93 -59,930 5,945,056
2004-08-03 2004-07-30 4 BIIB BIOGEN IDEC INC
Common Stock
S - Sale -300 100,200 -0.30 59.96 -17,988 6,007,992
2004-08-03 2004-07-30 4 BIIB BIOGEN IDEC INC
Common Stock
S - Sale -1,000 100,500 -0.99 60.00 -60,000 6,030,000
2004-08-03 2004-07-30 4 BIIB BIOGEN IDEC INC
Common Stock
M - Exercise 10,000 101,500 10.93 35.21 352,083 3,573,642
2004-08-02 3/A BIIB BIOGEN IDEC INC
Common Stock
37,318
2004-08-02 3/A BIIB BIOGEN IDEC INC
Common Stock
19,158
2004-08-02 3 BIIB BIOGEN IDEC INC
Common Stock
2004-08-02 3 BIIB BIOGEN IDEC INC
Common Stock
19,158
P
非衍生或衍生證券的公開市場或私下買入
S
非衍生或衍生證券的公開市場或私下賣出
A
公司向內部人員授予、獎勵或以其他方式獲取證券(例如股票期權)
C
衍生工具轉換
D
將證券賣出或轉讓回公司
F
使用從公司收到的證券的一部分來支付行使價或稅務負擔。
G
內部人士贈送或接收他人贈送公司股票
K
股權掉期和類似的避險交易
M
行使或轉換從公司獲得的衍生證券(例如期權)
V
內部人士透過Form 4自願報告的一筆交易
J
其他(附有交易描述的腳註)